In this webinar, you will learn:
- How MilliporeSigma’s Single Molecule Counting (SMC™) platform can be used to detect even very low levels of Huntingtin protein
- How to reach fM levels of sensitivity detecting both mHTT and total HTT
- Development and validation of High Sensitivity SMC™ Immunoassays
Sarah J. Hamren has led the SMC™ Custom Assay and Sample Testing group since 2015. She has over 30 years of experience in biopharma research and development. Previously the Director of Assay Development of the Life Science Division for Singulex, Sarah has been responsible for the successful transfer to MilliporeSigma of the Singulex Life Science business unit, marketing, sales, manufacturing, quality control, accounts receivable, international reagent shipment, and customer support since its 2015 acquisition. Drawing on her past experience working with Chiron Corporation, Bayer Corporation’s Biotechnology division, Tethys Bioscience, Singulex, and now MilliporeSigma, maintaining the high quality services clients expect from MilliporeSigma has been her constant goal. She is co-author on 15 peer-reviewed publications and holds two U.S. patents. Sarah’s 12 years of experience effectively partnering with a broad array of clients have culminated in hundreds of successful biomarker assay development projects.